Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Goodwill (2018 - 2025)

Summit Therapeutics (SMMT) has disclosed Goodwill for 6 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill changed 0.4% year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Sep 2025, changed 0.4%, and an annual FY2024 reading of $1.9 million, down 1.53% over the prior year.
  • Goodwill was $2.0 million for Q3 2025 at Summit Therapeutics, down from $2.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $2.0 million in Q1 2021 and bottomed at $1.9 million in Q4 2024.
  • Average Goodwill over 4 years is $2.0 million, with a median of $2.0 million recorded in 2024.
  • The sharpest move saw Goodwill surged 611.75% in 2021, then decreased 1.53% in 2024.
  • Year by year, Goodwill stood at $2.0 million in 2021, then decreased by 5.77% to $1.9 million in 2023, then fell by 1.53% to $1.9 million in 2024, then increased by 7.24% to $2.0 million in 2025.
  • Business Quant data shows Goodwill for SMMT at $2.0 million in Q3 2025, $2.0 million in Q2 2025, and $1.9 million in Q1 2025.